CF Industries (CF) Q2 2026 Earnings Call Transcript

CF Industries reported Q2 net earnings of $727M ($4.73/sh) and adjusted EBITDA of $1.2B, with high ammonia capacity utilization of 98% in 1H 2026. Management raised its mid-cycle EBITDA baseline to ~$2.9B (and to ~$3.3B by 2030) while projecting $1.3B of total 2026 capex and continued strong free-cash-flow generation of ~$1.8B over the trailing 12 months (50% EBITDA-to-FCF conversion). Capital returns accelerated: a 20% dividend increase to $0.60/sh and $958M of share repurchases (10.6M shares) over the trailing 12 months. The outlook leans supportive as global nitrogen fundamentals remain tight into 2027 amid higher capital costs, LNG/freight inflation (Middle East to U.S. Gulf freight at ~$70/ton vs ~$35 a year ago), and Iran-related supply disruptions.

Analysis

CF is getting a structural re-rate, not just a spot-commodity pop. The key mechanism is that higher global build costs and LNG-linked operating friction are lifting the marginal cost curve, so CF’s low-cost North American network can earn returns on incremental capital that were not available two years ago. That improves both earnings durability and the value of buybacks: retiring stock at a discount while cash generation stays high is a compounding engine, not a one-off capital return story.

The second-order loser set is broader than the call suggests. European and LNG-sensitive nitrogen producers face a double squeeze from feedstock economics and reliability risk, while import-dependent buyers in Brazil, India, and Southeast Asia may see more volatile procurement windows and higher working-capital needs into the next 2-3 quarters. CF’s own product-mix flexibility also matters: shifting toward urea and DEF raises realized margins, but it can tighten merchant availability in the channel and amplify seasonal price spikes.

The main risk is that the market has already priced too much of the Middle East premium into nitrogen. If shipping/insurance normalizes faster than expected or China meaningfully steps up exports beyond the current range, the near-term price support can unwind even if the mid-cycle floor remains higher. The next catalysts are fall application, India tender flow, and any Class VI/Blue Point milestone over the next 1-3 months; the 6-18 month story hinges on whether new capacity actually gets financed against the new hurdle rate. Contrarian view: consensus may be underestimating how much of CF’s valuation is now driven by capital allocation and replacement-cost scarcity, not just ammonia spot pricing. The thesis is falsified if NOLA urea fails to hold the incentive level in the mid-300s and global freight premiums retrace materially.

Key Decisions for Investors

• Long CF on post-earnings weakness over the next 2-6 weeks; target a 3-6 month hold into fall application and India tender season. Risk/reward favors upside if NOLA urea stays above the mid-300s; thesis breaks if pricing slides back below incentive levels and stays there for a full quarter.
• Pair trade: long CF / short MOS for 1-3 months. CF has cleaner nitrogen leverage, stronger free cash flow conversion, and more visible buyback support; MOS is more exposed to a broader ag basket where nitrogen upside is diluted. Cover the short if corn/farm economics improve sharply or phosphate tightness reasserts.
• Set a tactical alert on CF around any pullback tied to easing geopolitical headlines; add only if the stock de-risks while fall UAN/urea order books remain firm. This is a better entry than chasing after a headline-driven spike because the catalyst path is sequential, not immediate.
• Watch item, not a trade yet: Blue Point and Yazoo milestones over the next 1-2 quarters. If Blue Point cost discipline holds and Yazoo restart timing is not pushed again, CF deserves a higher mid-cycle multiple; if either project slips materially, expect the market to reintroduce a conglomerate-style discount.